Appendix 4C – Quarterly Report
Appendix 4C – Quarterly report for entities subjected to Listing Rule 4.7B: Download here.
ASX Announcements
Escrow Release
Escrow Release Click here to download.
Results of Annual General Meeting 2016
Click here to view the results of the AGM 2016.
Invitrocue Appoints DasGupta Ramanuj, Ph.D as Senior Scientific Director
23 November 2016 – Invitrocue (ASX:IVQ) is pleased to announce that Dr. Ramanuj DasGupta, Ph.D will be joining the company as Senior Scientific Director on 1 December 2016. Dr. DasGupta is a highly regarded professor in New York University School of Medicine with more than a decade of experience in cancer research and drug discovery. …
Appendix 4C – Quarterly Report
Appendix 4C – Quarterly report for entities subjected to Listing Rule 4.7B: Download here.
Annual General Meeting 2016
Invitrocue (ASX:IVQ) will be holding our inaugural AGM on the 30th of November. Click here for AGM Notice.
Invitrocue Signs Research Collaboration Agreement with Genome Institute of Singapore for Colorectal Cancer Organoids
October 24, 2016 – Invitrocue (ASX:IVQ) announced a collaboration agreement with the Cancer Therapeutics and Stratified Oncology Group at the Genome Institute of Singapore (GIS), A*STAR. Invitrocue and GIS will jointly conduct a pilot feasibility study using Invitrocue’s cell-based 3D scaffolding technology (Onco-PDO™) to culture colorectal cancer organoids. The aim of the study is to …
Annual Report For The Period Ended 30 June 2016
Annual Report Click here to view on ASX. Click here to view on Google Drive.
Addendum To Appendix 4E
September 08, 2016 – Invitrocue Limited (ASX: IVQ) has provided the following addendum to the Appendix 4E issued on 31 August for the period ended 30 June 2016. Reverse takeover (RTO) listing on 27 January 2016 During the year, Invitrocue Limited acquired all the shares of Invitrocue Pte Ltd by means of a scrip offer. …
InvitroCue Awarded A*STAR Tender
September 05, 2016 – InvitroCue (ASX:IVQ) has been awarded a tender by the Institute of Bioengineering and Nanotechnology, Agency for Science, Technology and Research (A*STAR), to supply and deliver Hepatocue 96-well plates and 3D-Cellusponge 96-well plates. A*STAR will be utilizing InvitroCue’s technologies to advance research on non-animal approaches to chemical safety testing under an international …